Quintrio
Home

ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS

Electromed, Inc.

ELMD

Electromed Inc is a United States-based company that develops, manufactures and markets airway clearance products that apply High Frequency Chest Wall Oscillation (HFCWO) therapy in pulmonary care for patients of all ages. The company markets its products in the U.S. to the homecare and hospital markets. Its product includes the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The company operates in a single segment: developing, manufacturing, and marketing medical equipment. The company generates revenue from Homecare, Hospital, Homecare Distributor, and Other.

Last trade $23.08
Day change -$0.02 (-0.09%)
Day range $22.79 – $23.33
Volume 22,504
Market cap $189M

Open XASE

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

Valuation

Market capitalization
$188.82M
Price / earnings
15.83×
Price / book
3.6×
Price / sales
2.5×
EV / sales
2.29×
EV / EBITDA
10.96×

Profitability

Earnings per share
$1.46
Return on assets
19.52%
Return on equity
22.73%
Dividend yield
0%

Liquidity and leverage

Debt / equity
0×
Current ratio
7.19×
Quick ratio
6.66×
Cash ratio
2.19×

Cash flow

Price / cash flow
19.13×
Price / free cash flow
21.69×
Free cash flow
$8.7M

Ratios use trailing-twelve-month financials and market data as of Nov 16, 2026.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

Income statement for ELMD, quarterly periods
Line itemQ1 FY2027 Sep 30, 2026Q4 FY2026 Jun 30, 2026Q3 FY2026 Mar 31, 2026Q2 FY2026 Dec 31, 2025Q1 FY2026 Sep 30, 2025Q4 FY2025 Jun 30, 2025Q3 FY2025 Mar 31, 2025Q2 FY2025 Dec 31, 2024
Revenue$18.68M$19.42M$18.58M$18.9M$16.89M$17.39M$15.68M$16.26M
Cost of revenue$3.75M$4.13M$3.93M$4.08M$3.69M$3.77M$3.46M$3.63M
Gross profit$14.94M$15.28M$14.64M$14.82M$13.2M$13.62M$12.23M$12.63M
Selling, general and administrative$11.17M$11.13M$10.52M$10.82M$10.29M$10.28M$9.81M$9.83M
Research and development$277K$328K$361K$384K$241K$302K$277K$251K
Total operating expenses$11.45M$11.46M$10.88M$11.2M$10.53M$10.58M$10.09M$10.09M
Operating income$3.49M$3.83M$3.77M$3.62M$2.67M$3.04M$2.14M$2.54M
Interest expense$148K$479K$0$0$134K$624K$0$0
Income before taxes$3.64M$3.96M$3.87M$3.73M$2.8M$3.18M$2.28M$2.69M
Income taxes$876K$560K$863K$968K$668K$971K$391K$726K
Net income$2.76M$3.4M$3M$2.76M$2.14M$2.2M$1.89M$1.97M
Net income attributable to common shareholders$2.76M$3.4M$3M$2.76M$2.14M$2.2M$1.89M$1.97M
EBITDA$3.76M$4.1M$4.05M$3.88M$2.93M$3.44M$2.42M$2.81M
Basic earnings per share$0.33$0.41$0.37$0.33$0.26$0.26$0.22$0.23
Diluted earnings per share$0.32$0.39$0.35$0.32$0.25$0.25$0.21$0.22

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2022

Upgrades Northcoast Research upgraded the previous rating for Ecolab Inc (NYSE:ECL) from Neutral to Buy. Ecolab earned $1.10 in the second quarter, compared to $1.22 in the year-ago quarter. The stock has a 52-week-high of $237.38 and a 52-week-low of $143.82. At the end of the last trading period, Ecolab closed at $161.64. According to Northcoast Research, the prior rating for The Toro Co (NYSE:TTC) was changed from Neutral to Buy. For the third quarter, Toro had an EPS of $1.19, compared to year-ago quarter EPS of $0.92. The current stock performance of Toro shows a 52-week-high of $103.10 and a 52-week-low of $71.86. Moreover, at the end of the last trading period, the closing price was at $82.67. According to UBS, the prior rating for Newmont Corp (NYSE:NEM) was changed from Neutral to Buy. For the second quarter, Newmont had an EPS of $0.46, compared to year-ago quarter EPS of $0.83. The current stock performance of Newmont shows a 52-week-high of $86.37 and a 52-week-low of $40.27. Moreover, at the end of the last trading period, the closing price was at $41.67. Rosenblatt upgraded the previous rating for Nexstar Media Group Inc (NASDAQ:NXST) from Neutral to Buy. For the second quarter, Nexstar Media Group had an EPS of $5.56, compared to year-ago quarter EPS of $4.51. The current stock performance of Nexstar Media Group shows a 52-week-high of $204.62 and a 52-week-low of $148.10. Moreover, at the end of the last trading period, the closing price was at $191.31. For Inter & Co Inc (NASDAQ:INTR), Goldman Sachs upgraded the previous rating of Sell to Neutral. The current stock performance of Inter & Co shows a 52-week-high of $4.63 and a 52-week-low of $2.10. Moreover, at the end of the last trading period, the closing price was at $4.20. Morgan Stanley upgraded the previous rating for NextEra Energy Inc (NYSE:NEE) from Equal-Weight to Overweight. In the second quarter, NextEra Energy showed an EPS of $0.81, compared to $0.71 from the year-ago quarter. At the moment, the stock has a 52-week-high of $93.65 and a 52-week-low of $67.22. NextEra Energy closed at $85.11 at the end of the last trading period. According to Redburn Partners, the prior rating for PPG Industries Inc (NYSE:PPG) was changed from Neutral to Buy. For the second quarter, PPG Indus had an EPS of $1.81, compared to year-ago quarter EPS of $1.94. At the moment, the stock has a 52-week-high of $177.32 and a 52-week-low of $107.06. PPG Indus closed at $123.76 at the end of the last trading period. According to Stifel, the prior rating for Mettler-Toledo International Inc (NYSE:MTD) was changed from Hold to Buy. For the second quarter, Mettler-Toledo Intl had an EPS of $9.39, compared to year-ago quarter EPS of $8.10. The stock has a 52-week-high of $1699.11 and a 52-week-low of $1082.78. At the end of the last trading period, Mettler-Toledo Intl closed at $1195.02. For Perrigo Co PLC (NYSE:PRGO), Wells Fargo upgraded the previous rating of Equal-Weight to Overweight. Perrigo earned $0.43 in the second quarter, compared to $0.50 in the year-ago quarter. The stock has a 52-week-high of $43.90 and a 52-week-low of $31.32. At the end of the last trading period, Perrigo closed at $36.74. According to Wolfe Research, the prior rating for Tesla Inc (NASDAQ:TSLA) was changed from Peer Perform to Outperform. Tesla earned $0.76 in the second quarter, compared to $0.48 in the year-ago quarter. At the moment, the stock has a 52-week-high of $402.67 and a 52-week-low of $206.86. Tesla closed at $270.21 at the end of the last trading period. BTIG upgraded the previous rating for Transocean Ltd (NYSE:RIG) from Neutral to Buy. Transocean earned $0.10 in the second quarter, compared to $0.18 in the year-ago quarter. At the moment, the stock has a 52-week-high of $5.56 and a 52-week-low of $2.32. Transocean closed at $3.56 at the end of the last trading period. BMO Capital upgraded the previous rating for Greif Inc (NYSE:GEF) from Underperform to Market Perform. Greif earned $2.35 in the third quarter, compared to $1.93 in the year-ago quarter. The stock has a 52-week-high of $72.80 and a 52-week-low of $53.65. At the end of the last trading period, Greif closed at $67.26. RBC Capital upgraded the previous rating for Rollins Inc (NYSE:ROL) from Sector Perform to Outperform. In the second quarter, Rollins showed an EPS of $0.20, compared to $0.20 from the year-ago quarter. The stock has a 52-week-high of $39.20 and a 52-week-low of $28.50. At the end of the last trading period, Rollins closed at $33.74. Jefferies upgraded the previous rating for Tsakos Energy Navigation Ltd (NYSE:TNP) from Hold to Buy. For the first quarter, Tsakos Energy Navigation had an EPS of $0.12, compared to year-ago quarter EPS of $0.71. The stock has a 52-week-high of $16.48 and a 52-week-low of $6.95. At the end of the last trading period, Tsakos Energy Navigation closed at $15.40. For Organon & Co (NYSE:OGN), Piper Sandler upgraded the previous rating of Neutral to Overweight. For the second quarter, Organon had an EPS of $1.25, compared to year-ago quarter EPS of $1.72. At the moment, the stock has a 52-week-high of $39.48 and a 52-week-low of $28.32. Organon closed at $28.50 at the end of the last trading period. For Frontline Ltd (NYSE:FRO), Jefferies upgraded the previous rating of Hold to Buy. In the second quarter, Frontline showed an EPS of $0.21, compared to $0.12 from the year-ago quarter. The current stock performance of Frontline shows a 52-week-high of $12.57 and a 52-week-low of $6.10. Moreover, at the end of the last trading period, the closing price was at $11.92. For Euronav NV (NYSE:EURN), Jefferies upgraded the previous rating of Hold to Buy. In the second quarter, Euronav showed an EPS of $0.02, compared to $0.44 from the year-ago quarter. The current stock performance of Euronav shows a 52-week-high of $17.24 and a 52-week-low of $7.91. Moreover, at the end of the last trading period, the closing price was at $16.23. See all analyst ratings upgrades. Downgrades For Signify Health Inc (NYSE:SGFY), William Blair downgraded the previous rating of Outperform to Market Perform. Signify Health earned $0.85 in the second quarter, compared to $0.00 in the year-ago quarter. The current stock performance of Signify Health shows a 52-week-high of $29.88 and a 52-week-low of $10.70. Moreover, at the end of the last trading period, the closing price was at $28.77. According to Dawson James, the prior rating for Arcimoto Inc (NASDAQ:FUV) was changed from Neutral to Sell. In the second quarter, Arcimoto showed an EPS of $0.39, compared to $0.23 from the year-ago quarter. At the moment, the stock has a 52-week-high of $8.27 and a 52-week-low of $1.93. Arcimoto closed at $2.00 at the end of the last trading period. JP Morgan downgraded the previous rating for Carlyle Secured ...Full story available on Benzinga.com

Zacks Investment Research

Bears are Losing Control Over Electromed, Inc. (ELMD), Here's Why It's a 'Buy' Now

Electromed, Inc. (ELMD) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

Zacks Investment Research

Electromed, Inc. (ELMD) Lags Q1 Earnings Estimates

Electromed, Inc. (ELMD) delivered earnings and revenue surprises of -16.67% and 11.12%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research

Electromed, Inc. (ELMD) Reports Next Week: What Awaits?

Electromed, Inc. (ELMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

No prior dividend records found.

Stock splits

Historical share-structure events and their execution dates.

Updated daily

No stock split records found.